Submitted: 27 Aug 2021
Accepted: 20 Oct 2021
ePublished: 05 Nov 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Prev Epidemiol. 2022;7(1): e13.
doi: 10.34172/jpe.2022.13
  Abstract View: 493
  PDF Download: 234


The survival rate of Iranian breast cancer patients with focus on prognostic factors

Abdolhasan Talaiezadeh 1 ORCID logo, Saghar Babadi 2* ORCID logo, Pedram Nazari 1* ORCID logo

1 Cancer Research Center, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran.
2 Student Research Committee, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran
*Corresponding Authors: Correspondence to: Saghar Babadi, Email: , Email: babadisaghar@gmail.com; Correspondence to: Pedram Nazari, Email: , Email: nazari.p@ ajums.ac.ir


Introduction: Breast cancer is the most prevalent cancer in women. Several studies showed that TNM stage, grade cancer, lymph node involvement, and the status of hormone receptors are the most important factor of breast cancer prognosis.

Objectives: To evaluate the clinical characteristics, prognostic factors, and survival rate in patients with breast cancer who underwent surgery in Ahvaz, Southwest of Iran.

Patients and Methods: This historical cohort study was conducted on 561 patients who underwent surgery for breast cancer between May 1997 and June 2016. Clinical characteristics, pathological profile, stage, and treatments of the patients were recorded. The prognostic factor, two and five-year overall survival (OS) rates, disease-free survival (DFS) were evaluated by the Cox proportional hazards model and the Kaplan-Meier test, respectively.

Results: The two and five-year OS rates were 92.1% and 81.7%, respectively. The most important prognostic factors in breast cancer survival were age, the size of the tumor, regional lymph node involvement, metastasis, stage, relapse, estrogen receptor (ER), progesterone receptor (PR), and hormone therapy. There was no significant relationship between tumor type, tumor site, metastasis, surgery kind, chemotherapy, radiation therapy, and the status of human epidermal growth factor receptor 2 (HER2) and the five-year survival rate.

Conclusion: This study showed that the most important factors affecting the high survival rate of patients with breast cancer are hormonal receptors, non-involvement of the lymph nodes, early-stage cancer, no recurrence, and no metastasis.

Citation: Talaiezadeh A, Babadi S, Nazari P. The survival rate of Iranian breast cancer patients with focus on prognostic factors. J Prev Epidemiol. 2022;7(1):e13. doi: 10.34172/jpe.2022.13.
First Name
Last Name
Email Address
Security code

Abstract View: 494

Your browser does not support the canvas element.

PDF Download: 234

Your browser does not support the canvas element.